Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN951533 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Cbp/p300-Interacting Transactivator, with Glu/Asp-Rich Carboxy-terminal Domain, 2 (CITED2) (AA 207-234), (C-Term) antibody
- Antibody type
- Polyclonal
- Description
- Affinity chromatography on Protein A
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Epitope
- C-Term, AA 207-234
- Vial size
- 0.4 mL
- Storage
- Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references CITED2 mechanoregulation of matrix metalloproteinases.
Identification of prospective factors promoting osteotropism in breast cancer: a potential role for CITED2.
[Mutation analysis of Cited2 in patients with congenital heart disease].
Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium.
CITED2 and NCOR2 in anti-oestrogen resistance and progression of breast cancer.
Sun HB
Annals of the New York Academy of Sciences 2010 Mar;1192:429-36
Annals of the New York Academy of Sciences 2010 Mar;1192:429-36
Identification of prospective factors promoting osteotropism in breast cancer: a potential role for CITED2.
Lau WM, Weber KL, Doucet M, Chou YT, Brady K, Kowalski J, Tsai HL, Yang J, Kominsky SL
International journal of cancer 2010 Feb 15;126(4):876-84
International journal of cancer 2010 Feb 15;126(4):876-84
[Mutation analysis of Cited2 in patients with congenital heart disease].
Yang XF, Wu XY, Li M, Li YG, Dai JT, Bai YH, Tian J
Zhonghua er ke za zhi = Chinese journal of pediatrics 2010 Apr;48(4):293-6
Zhonghua er ke za zhi = Chinese journal of pediatrics 2010 Apr;48(4):293-6
Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium.
Ganesh SK, Zakai NA, van Rooij FJ, Soranzo N, Smith AV, Nalls MA, Chen MH, Kottgen A, Glazer NL, Dehghan A, Kuhnel B, Aspelund T, Yang Q, Tanaka T, Jaffe A, Bis JC, Verwoert GC, Teumer A, Fox CS, Guralnik JM, Ehret GB, Rice K, Felix JF, Rendon A, Eiriksdottir G, Levy D, Patel KV, Boerwinkle E, Rotter JI, Hofman A, Sambrook JG, Hernandez DG, Zheng G, Bandinelli S, Singleton AB, Coresh J, Lumley T, Uitterlinden AG, Vangils JM, Launer LJ, Cupples LA, Oostra BA, Zwaginga JJ, Ouwehand WH, Thein SL, Meisinger C, Deloukas P, Nauck M, Spector TD, Gieger C, Gudnason V, van Duijn CM, Psaty BM, Ferrucci L, Chakravarti A, Greinacher A, O'Donnell CJ, Witteman JC, Furth S, Cushman M, Harris TB, Lin JP
Nature genetics 2009 Nov;41(11):1191-8
Nature genetics 2009 Nov;41(11):1191-8
CITED2 and NCOR2 in anti-oestrogen resistance and progression of breast cancer.
van Agthoven T, Sieuwerts AM, Veldscholte J, Meijer-van Gelder ME, Smid M, Brinkman A, den Dekker AT, Leroy IM, van Ijcken WF, Sleijfer S, Foekens JA, Dorssers LC
British journal of cancer 2009 Dec 1;101(11):1824-32
British journal of cancer 2009 Dec 1;101(11):1824-32
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- Confocal immunofluorescent analysis of CITED2 Antibody (C-term) (Cat. #AP50928PU-N) with Hela cell followed by Alexa Fluor® 489-conjugated goat anti-rabbit lgG (green). DAPI was used to stain the cell nuclear (blue).